Search

2019 ICO-Allergan Research Fellowship awarded

Dr Matias Iglicki, from the University of Buenos Aires in Argentina, has been selected as the second recipient of the International Council of Ophthalmology (ICO)-Allergan Fellowship Award, by a panel of leading experts.

BCLA ASIA 2024 triumphantly takes place in Chengdu, China

The British Contact Lens Association (BCLA) marked an historic milestone with the successful staging of BCLA ASIA in mainland China.

Outcomes at 100 weeks from the LEAVO study of intravitreal anti-VEGF therapies for macular oedema secondary to central retinal vein occlusion

Royal College of Ophthalmologists Annual Congress 2019, Glasgow - First presented and discussed on Monday 20 May 2019, with a further presentation of results during Retina Subspecialty Day on Thursday 23 May 2019. Among patients with macular oedema secondary to...

Oculomics and Big Data changes the game for Medical Ophthalmologists

Oculomics and Big Data changes the game for Medical Ophthalmologists, and here's why.

World-first artificial intelligence foundation model for eye care to supercharge global efforts to prevent blindness

Researchers at Moorfields Eye Hospital and UCL Institute of Ophthalmology (IoO) have developed an artificial intelligence (AI) system that has the potential to not only identify sight-threatening eye diseases but also predict general health, including heart attacks, stroke and Parkinson’s disease.

Wearing glasses boosts income by a third in low-income communities, finds landmark new study

A pair of reading glasses increases the earnings of people in low-income communities by 33% according to new research.

Major survey calls for new ideas on how to reinvent post diagnostic support for blind and partially sighted people

The Royal National Institute of Blind People (RNIB) is launching a new research study to better understand post-diagnostic support across the sight loss sector. People who have experienced being diagnosed with a sight condition know it’s not always easy to...

Study flags evidence gaps in AI eye imaging devices approved for patient care

Uneven evidence and poor data transparency revealed in review of AI as a medical device. A review of regulator-approved medical AI models in eye care has found that they vary widely in providing evidence for clinical performance and lacked transparency...

Treatment for cause of sudden sight loss now available through the NHS in England

The National Institute for Health and Care Excellence (NICE) has approved a treatment for Leber Hereditary Optic Neuropathy (LHON), called Idebenone (Raxone), in those aged 12 and above who are affected by the condition. LHON is a rare mitochondrial genetic...

The College of Optometrists announces new research scholarships, grants and bursaries are open for applications

The College of Optometrists has announced its programme of financial support for undergraduate students, postgraduate students and members engaging in research projects in the 2025-2026 academic year is open for applications. The College has a long history of providing financial...

NICE approves treatment for cause of sudden sight loss

The National Institute for Health and Care Excellence (NICE) has approved a treatment for Leber Hereditary Optic Neuropathy (LHON), called Idebenone (Raxone), in those aged 12 and above who are affected by the condition. LHON is a rare mitochondrial genetic...